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Recent studies of N-terminal acetylation have identified new N-terminal acetyltransferases (NATs) 
and expanded the known functions of these enzymes beyond their roles as ribosome-associated co-
translational modifiers. For instance, the identification of Golgi- and chloroplast-associated NATs 
shows that acetylation of N-termini also happens post-translationally. In addition, we now appreciate 
that some NATs are highly specific: for example, a dedicated NAT responsible for post-translational 
N-terminal acetylation of actin was recently revealed. Other studies have extended NAT function 
beyond Nt-acetylation, including functions as lysine acetyltransferases (KATs) and non-catalytic roles. 
Finally, emerging studies emphasize the physiological relevance of N-terminal acetylation, including 
roles in calorie restriction-induced longevity and in pathological α-synuclein aggregation, relevant for 
Parkinson’s disease. Combined, the NATs rise as multifunctional proteins and N-terminal acetylation 
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N-terminal acetylation – an abundant and regulated protein modification 
N-terminal (Nt) acetylation is among the most common protein modifications in eukaryotic cells. In 
fact, a majority of the proteome is Nt-acetylated (Arnesen et al., 2009; Bienvenut et al., 2012). This 
applies to both soluble cytosolic proteins as well as transmembrane proteins (Aksnes et al., 2015c). 
Nt-acetylation refers to the addition of an acetyl group to the N-terminus of a protein, i.e. the amino 
group on the -carbon of the first amino acid in the protein (Figure 1).  The source of the acetyl group 
is acetyl coenzyme A (Ac-CoA) and the transfer of acetyl is catalyzed by N-terminal 
acetyltransferases (NATs) (Aksnes et al., 2016). In contrast, the more extensively investigated 
acetylation of internal lysines is catalyzed by lysine acetyltransferases (KATs) and this reaction is 
reversible by the action of lysine deacetylases (KDACs) (Drazic et al., 2016). No deacetylase acting 
on acetylated N-termini has been identified, leading to the assumption that Nt-acetylation is both 
irreversible and completely static. However, recent studies suggest that it is probably more complex 
than that. 
This review provides a summary of these and other recent advances in our knowledge on N-terminal 
acetylation as well as point to new knowledge concerning the NATs and their cellular roles. The 
overall scope is a timely and complete overview of the cotranslational, posttranslational and non-
catalytic roles of this enzyme family, including its most recent member, the actin Nt-acetyltransferase.   
 
Figure 1: Protein N- and N-acetylation. Protein N-acetyltransferases catalyze the transfer of an acetyl group 
from acetyl-CoA (green, acetyl group in yellow) onto a substrate protein. An N-terminal acetyltransferase (NAT, 
top panel) targets the -amino group (red) of the N-terminal residue, whereas a lysine acetyltransferase (KAT, 
bottom panel) targets the -amine group (red) of an internal lysine. targets. Lysines can be deacetylated by a 
lysine deacetylase (KDAC), while currently, no N-terminal deacetylases (NDACs) are known, and N-terminal 
acetylation is thus considered irreversible. 
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Regulation of N-terminal acetylation 
Recent reports of cases in which N-terminal acetylation is reduced or increased as a response 
to certain factors, challenge the prevailing view of this modification as constitutive and static. In 
cancer cells, fluctuations in Ac-CoA was found to impact the level of Nt-acetylation and thereby 
apoptotic fate (Yi et al., 2011). On the contrary, in yeast cells exposed to huge variations in Ac-CoA 
concentration the bulk of the proteome was remarkably unaffected in its Nt-acetylation state, albeit 
some exceptions suggested a more specific regulation for a part of the proteome (Varland et al., 
2018a). In plants, drought stress was found to potentially regulate Nt-acetylation levels (Linster et al., 
2015). In this case, drought-induced phytohormone abscisic acid signaling downregulated the major 
NAT, NatA, with a concomitant increase in free N-termini.. Downregulation of NatA resulted in plant 
adaptation and thereby drought resistance. A perhaps similar recent finding is that in yeast, calorie 
restriction downregulates NatD as well as reduces the Nt-acetylation of a specific substrate, leading to 
increased stress resistance and longevity, further described below (Molina-Serrano et al., 2016). 
Another example is that NAA10, the catalytic subunit of NatA, is hydroxylated during normoxia 
therein changing its enzymatic properties (Kang et al., 2018), as discussed below. So, although still 
immature, current data suggest that Nt-acetylation may be regulated both via Ac-CoA-levels and 
NAT-levels/function to mediate organismal and cellular signaling.        
 
The Nt-acetylome 
The currently known eight members of the NAT family all have distinctive features 
(summarized in Figure 2). Many NATs have a broad substrate specificity and together the NAT 
substrate classes make up the Nt-acetylome. Whether or not a protein is modified, and by which NAT, 
is mainly determined by the identity of the first two amino acids at the N-terminus (Figure 2, column 
3). If the second amino acid is relatively small (G, A, V, S, T, C, P), the initiator methionine (iMet) is 
in most cases cleaved by methionine aminopeptidases (MetAPs) (Frottin et al., 2006), after which 
NatA may potentially acetylate the newly exposed N-terminus (Arnesen et al., 2009; Mullen et al., 
1989; Polevoda et al., 1999). Among this group of substrates there are large differences: Ser- N-
termini are for instance almost always Nt-acetylated while Gly- N-termini are rarely acetylated and 
Pro- N-termini are almost never acetylated (Arnesen et al., 2009; Goetze et al., 2009; Van Damme et 
al., 2011b). For suboptimal substrates, partial Nt-acetylation is often observed. With its broad 
specificity, NatA is the major NAT acetylating thousands of different proteins, representing ⁓40% of 
the human proteome (Figure 2, column 4). In contrast, NatD, which also acetylates Ser- starting N-
termini, is highly specific for histones H2A and H4 (Hole et al., 2011; Song et al., 2003). 
The iMet-retaining N-termini are modified by other enzymes. Met-“Asx/Glx”-type N termini 
(MD-, ME-, MN-, and MQ-starting) are almost 100% Nt-acetylated by NatB (Van Damme et al., 
2012) whereas other Met- N-termini (like ML-, MI-, MF-, MY-, MK-, MT-starting) are more variably 
Nt-acetylated by NatC, NatF and NatE (Figure 2, column 3) (Aksnes et al., 2015c; Van Damme et al., 
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2011a; Van Damme et al., 2015; Van Damme et al., 2011b; Van Damme et al., 2016). While NatB 
alone acetylates ⁓20% of the human proteome, the combined actions of NatC, NatE and NatF 
accounts for the same number (Figure 2, column 4). The distinguishing factors between the substrates 
for each of these three NATs is less defined (Aksnes et al., 2016). However, NatF specifically Nt-
acetylates membrane proteins.  
Taking these three substrate classes together, the total fraction of the proteome that is Nt-
acetylated, also called the Nt-acetylome, is ⁓80% in humans. In chloroplasts, proteins with various N-
termini (M, A, S, T) are Nt-acetylated by NatG (Dinh et al., 2015). Finally, in the animal kingdom, 
actins are uniquely processed by a peptidase to generate mature acidic actin N-termini starting with 
several Asp or Glu residues (Redman and Rubenstein, 1981; Rubenstein and Martin, 1983). The actins 










Figure 2. The eukaryotic N-terminal acetyltransferases. Overview of the composition and characteristics of the 
eight currently known eukaryotic NATs, NatA to NatH (column 1). The catalytic subunits (NAA10 to NAA80) 
typically associate with up to two auxiliary subunits (NAA15, NAA25, NAA35, and NAA38) that contribute to 
activity of the NAT complex through ribosome anchoring and/or substrate specificity-modulation (column 2). NATs 
have specificity towards different proteins based on the identity of mainly the first two amino acids (column 3) 
(Aksnes et al., 2016). Taking into account the abundance of each N-termini subtype in the proteome, each NAT is 
estimated to acetylate a certain percentage of the proteome (column 4) (Aksnes et al., 2016; Aksnes et al., 
2015c). NATs vary in their intracellular distribution from cytosolic and ribosome associated (NatA-NatE) to Golgi 
membrane (NatF), organelle lumen (NatG) and cytosolic but non-ribosomal (NatH) (column 5). In addition, some 
of the NAT catalytic subunits appear to additionally localize to the nucleus (e.g., NAA10, NAA40 and NAA50; not 
specifically denoted). The traditional ribosome-associated NATs are well conserved, whereas the more recently 
discovered NATs performing post-translational Nt-acetylation, are less conserved (column 6). R, Ribosome; GM, 
Golgi membrane; C, Chloroplast. 
 
Crosstalk with other N-terminal modifications 
A major proportion of the eukaryotic proteome is Nt-acetylated. So what about the remaining 
fraction that is not Nt-acetylated? These protein N-termini are not necessarily unmodified. In fact, 
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protein N-termini may undergo several different modifications. This embeds a layer of regulatory 
complexity to protein N-termini and opens for a functional interplay between different modifications 
at the N-terminus (Varland et al., 2015). For instance, Gly-starting N-termini (after iMet removal) are 
less frequently Nt-acetylated than many other types of N-termini (Arnesen et al., 2009) and a recent 
global investigation of Gly-N-termini not only revealed that many proteins were Nt-myristoylated 
instead of Nt-acetylated, but also that several specific proteins could dually exist in either Nt-
acetylated or Nt-myristoylated states (Castrec et al., 2018).  
Another example involves the Ser-starting myosin regulatory light chain 9 (MYL9) which is 
present in both Nt-acetylated and Nt-methylated states in vivo (Petkowski et al., 2012). Interestingly, 
these two modification states of MYL9 were recently described to be differentially modified also by 
internal PTMs, and to further have different binding properties, as well as promote different cellular 
roles (Nevitt et al., 2018). This work showed that Nt-acetylation of MYL9 is associated with increased 
phosphorylation at serine 19, as well as skewing towards MYL9’s cytoplasmic roles, whereas 
exclusive Nt-methylation is associated with increased DNA binding and increased nuclear function as 
a transcription factor while additionally also negatively impacting interactions between the MYL9 N-
terminus and several cytoskeletal proteins.  
Other types of interplay includes NatD mediated Histone H4 Nt-acetylation which was found 
to block H4Arg3 methylation in one case and H4Ser1 phosphorylation in another, impacting 
transcription from such promoters (Ju et al., 2017; Schiza et al., 2013). A recent study found an 
inverse relationship between protein Nt-ubiquitination and Nt-acetylation (Akimov et al., 2018). 
Among the here detected Nt-ubiquitinated proteins, there was an over-representation of Pro- and Val- 
starting proteins, i.e. types of N-termini known to rarely be Nt-acetylated (Aksnes et al., 2016). 
Interestingly, this work also suggested that Nt-ubiquitination likely has more roles than merely being a 
label for degradation.  
 
 
The eukaryotic NAT machinery 
The NAT machinery is classically thought to act co-translationally, and the five established 
ribosome associated NATs (NatA to NatE) are highly conserved among eukaryotes (Figure 2, column 
5 and 6) (Aksnes et al., 2016). Each NAT has a catalytic subunit and all but one of these ribosomal 
NATs have a dedicated ribosomal anchor subunit (Polevoda et al., 2008).  
NatA was first discovered in Saccharomyces cerevisiae and is composed of the catalytic 
subunit NAA10 and the auxiliary subunit NAA15 (Figure 2, column 2) (Arnesen et al., 2005a; Mullen 
et al., 1989; Park and Szostak, 1992). NAA15 is essential for NatA activity in two ways: it acts as a 
ribosomal anchor via contacts to the ribosome (Gautschi et al., 2003; Magin et al., 2017; Varland and 
Arnesen, 2018), and it modulates the substrate specificity of NAA10 (Liszczak et al., 2013). While 
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monomeric NAA10 may target acidic amino acids (at least in vitro), the bulk of cellular NAA10 is 
bound to NAA15 and this complex prefers substrate N-termini starting with small amino acids like Ser 
and Thr (Liszczak et al., 2013; Van Damme et al., 2011a). The anchoring of NatA to the ribosome was 
recently revealed to involve binding to ribosomal RNA expansion segments thus positioning NatA 
dynamically underneath the polypeptide exit tunnel (Knorr et al., 2019). The Huntingtin interactor and 
chaperone-like protein HYPK (Raychaudhuri et al., 2008) was found to be a stably associated 
component of the human NatA complex and further to be important for proper NatA mediated Nt-
acetylation of cellular proteins (Arnesen et al., 2010). The structures of the human and C. 
thermophilum NAA10-NAA15-HYPK complexes were recently revealed, and biochemical studies 
interestingly identified HYPK as a negative regulator of NatA activity (Gottlieb and Marmorstein, 
2018; Weyer et al., 2017). Further investigations are required to define the overall impact of HYPK 
for NatA activity in cells and in vivo, but these data may imply that HYPK may act as an essential 
component of NatA ensuring quality control of this enzymatic process.   
NatB is composed of the catalytic subunit NAA20 and the auxiliary subunit NAA25 
(Polevoda et al., 2003; Starheim et al., 2008). NAA25 wraps around NAA20 in a similar way as 
observed for NAA15 and NAA10 (Hong et al., 2017), but the catalytic site of NAA20 is specialized to 
accommodate its large cellular pool of MD, ME, MN and MQ substrates.  
The NatC complex acetylates a large variety of Met-hydrophobic N-termini and is the third of 
the major NATs (Polevoda et al., 1999; Tercero et al., 1993; Van Damme et al., 2016). NatC subunits 
NAA30 and NAA35 are analogues to the catalytic and ribosomal anchor subunits of the NatA and 
NatB complexes (Polevoda and Sherman, 2001; Starheim et al., 2009), but their structures remain to 
be solved. The small NAA38 subunit which has been identified in both S. cerevisiae and human NatC 
has not yet been functionally defined, but its Sm-like domain may suggest a role in RNA-binding.  
NatD is the only human ribosomal NAT without a known ribosomal anchor subunit since it is 
solely composed of the catalytic NAA40 (Hole et al., 2011; Song et al., 2003). Its catalytic core is 
specifically designed to accommodate its only two known substrates, histones H2A and H4 (Magin et 
al., 2015). The N-termini of these histones are first processed by MetAP, similar to NatA substrates, 
before the Ser residues are Nt-acetylated by NatD. Thus, NatD is unique among these ribosomal NATs 
in terms of the lack of additional subunits as well as its highly selective substrate pool.  
NatE is defined as the activity of the catalytic NAT-subunit NAA50 that may physically 
associate with NAA10 and NAA15 (Arnesen et al., 2006a; Gautschi et al., 2003; Williams et al., 
2003). NAA50 may act alone towards Met-hydrophobic N-termini, but when in complex with 
NAA10-NAA15 it will be anchored to the ribosome and might then act on the rare NatA-type N-
termini for which the iMet has not been removed by MetAPs (Met-Ser, Met-Thr etc.) (Evjenth et al., 
2009; Van Damme et al., 2011a; Van Damme et al., 2015).  
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While these five ribosomal NATs may be considered as a part of the co-translational 
machinery common for all eukaryotes, the most recently identified NATs are mostly more specialized 
both in terms of defined post-translational actions and their presence in only some eukaryotic species. 
NatF is composed of the catalytic NAA60 which is present in multicellular eukaryotes like 
animals and plants, but not in unicellular yeast (Van Damme et al., 2011b). It acetylates a variety of 
Met-starting N-termini and its natural substrates appear to be defined to the cytosolic N-termini of 
transmembrane proteins (Aksnes et al., 2015c). NAA60 has a C-terminal extension, not present in 
other NATs, that integrates into the cytosolic surface of the Golgi membrane (Aksnes et al., 2017). 
This points to a post-translational activity for NAA60. 
NatG is defined as the plant kingdom specific NAA70 enzyme (Dinh et al., 2015). A variety 
of Arabidopsis thaliana proteins are imported into chloroplasts and are post-translationally Nt-
acetylated following import. NAA70 is localized to the chloroplast stroma and displays a broad NAT 
substrate specificity, thus making it likely that it is responsible for a portion of these chloroplast 
lumenal Nt-acetylation events in addition to cotranslational Nt-acetylation of proteins encoded by the 
plastid genome (Dinh et al., 2015). Further, the authors found several additional putative chloroplast-
localized NATs that may complete this picture in the near future, however a plastoribosomal 
anchoring subunit for AtNAA70 has not been described.  
NatH/NAA80 is the most recently described member of the NAT family (Drazic et al., 2018). 
This NAT is neither ribosome associated, nor organelle localized, thus performing its Nt-acetylation 
post-translationally in the cytosol. Here, NAA80, which is a highly selective NAT, acts on one of the 
most abundant cytosolic proteins, namely actin. Both - and -actin are proven substrates of NAA80 
and it is likely that also the remaining four actins are NAA80 substrates (Drazic et al., 2018; 
Rubenstein and Martin, 1983; Wiame et al., 2018). All actins have a negatively-charged N-terminus 
and NAA80’s specificity for this type of N-terminus was explained as the structure of Drosophila 
NAA80 was solved in complex with a peptide-CoA bi-substrate analog mimicking the N-terminus of 
β-actin (Goris et al., 2018). NAA80-mediated actin Nt-acetylation is part of a unique animal-specific 
stepwise N-terminal processing in which Nt-acetylation actually occurs twice (Figure 3) (Berger et al., 
1981; Redman and Rubenstein, 1981; Rubenstein and Martin, 1983). For animal - and -actin (Class 
I actins), an initiator Methionine that is initially cotranslationally Nt-acetylated by NatB (Van Damme 
et al., 2012), is removed by an aminopeptidase in the proceeding step (Redman and Rubenstein, 1981; 
Rubenstein and Martin, 1983). The newly exposed N-terminus is highly acidic and NAA80-mediated 
Nt-acetylation further ensures acidity by removing the positive charge on the -amino group in the 
final step. The first and cotranslational Nt-acetylation step in actin processing is common for all 
eukaryotes and depends on NatB/NAA20, whereas the posttranslational steps are specific for animals, 
which express both NatH/NAA80 and acidic actin N-termini, suggesting coevolution of this NAT with 
such actin N-termini (Drazic et al., 2018). The N-terminus of the Class II actins match the substrate 
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specificity of NatA after iMet removal. After the initial acetylation these probably undergo the same 
post-translational processing as Class I actins.   
To summarize, the NATs together provide Nt-acetylation for a majority of the proteome. In 
terms of substrate classes of N-termini, the major NATs appear to be accounted for. However, 
additional high-specificity NATs, like NatD and NatH may yet remain to be identified. Additionally, 
NATs acting posttranslationally on digested N-termini, as well as NATs localized to the organelle 
interior also possibly exist. 
 
 
Figure 3. N-terminal processing of actin. In eukaryotes, the Class I actins, - and -actin, match the substrate 
specificity of NatB and are co-translationally Nt-acetylated by NatB. This acetylated methionine is next cleaved off 
probably by the enzymatic action of an unidentified aminopeptidase. The newly exposed N-terminus is post-
translationally Nt-acetylated by NatH/NAA80. These post-translational steps are specific for animals. The Class II 
actins, muscle - and -actin, likely undergo co-translational NatA-mediated Nt-acetylation after iMet removal and 
then follow the same post-translational processing as the Class I actins. 
 
Impact of protein Nt-acetylation: from protein to organism 
For the highly selective N-terminal acetyltranserase, NatH/NAA80, identification of the 
consequence of the Nt-acetyl group is measurable from protein level to cellular phenotypes. For the 
more typical NAT, that causes Nt-acetylation of many thousands of proteins, it can be challenging to 
connect effects at the protein level to specific cellular and organismal phenotypes. The studies 
describing impact of the Nt-acetyl group at the protein level show that Nt-acetylation can have quite 
diverse effects on the receiving proteins (Figure 4A). 
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Nt-acetylation impacts protein interactions and complex formation 
Several studies show a direct involvement of the Nt-acetyl group in protein-protein 
interactions and protein complex formation (Figure 4A-I). The NatC Nt-acetylated Met-1 of the E2 
enzyme UBC12 (human UBE2M) binds in a hydrophobic pocket in the E3 DCN1 (human 
DCUN1D1) (Scott et al., 2011), and this type of interaction is common for mammalian NEDD8 
ligation enzymes (Monda et al., 2013). This direct involvement of the Nt-acetyl group in protein 
binding was recently antagonized by inhibitors with selectivity for the Nt-acetyl pockets of DCN1 and 
DCN2 (Scott et al., 2017). Nt-acetylation may also indirectly affect binding, such as for Sir3’s binding 
to the nucleosome in which the Nt-acetylation dependency is explained by stabilization of a binding 
loop (Arnaudo et al., 2013; Yang et al., 2013).   
 
Nt-acetylation impacts protein subcellular targeting 
Nt-acetylation can be crucial for correct subcellular localization. Several yeast proteins 
mislocalize in the absence of their respective NAT (Aksnes et al., 2015b; Behnia et al., 2004; Setty et 
al., 2004). However, despite attempts, Nt-acetylation could not thus far be defined as a global 
localization determinant in yeast (Aksnes et al., 2013; Caesar et al., 2006). In fact, some proteins that 
are localized by means of their Nt-acetyl group actually require it for protein-protein interaction at the 
localization site. In the plant Arabidopsis thaliana, Nt-acetylation by NatC is required for efficient 
photosynthesis and it was suggested that certain chloroplast precursor protein(s) were dependent on 
their Nt-acetyl group for chloroplast localization (Pesaresi et al., 2003).  
An example of a human Nt-acetylated protein directly interacting with the membrane is -
synuclein, a protein that is implicated in Parkinson’s disease. Here, Nt-acetylation, together with 
copper binding to the Nt-region, stabilizes an N-terminal -helix thereby increasing -synuclein’s 
affinity for membranes (Dikiy and Eliezer, 2014; Miotto et al., 2015). Another subcellular targeting 
mechanism in which Nt-acetylation appears to play an important role, is post-translational 
translocation across the endoplasmic reticulum (ER) membrane. Here, the Nt-acetyl group was found 
to be part of an early targeting step inhibiting the signal recognition particle (SRP)-independent 
pathway for post-translational translocation through the Sec62 channel (Forte et al., 2011).  
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Figure 4. Implications of the N-terminal acetyl group. 
(A) A wide spectrum of protein functioning can be affected by Nt-acetylation. Nt-acetylation may be involved in 
protein-protein interactions. The interaction can directly involve the Nt-acetyl group’s insertion in a hydrophobic 
binding groove like depicted here or the modification can stabilize a binding region. Correct subcellular 
localization may be obscured in the absence of Nt-acetylation and in some cases the Nt-acetyl group may 
stabilize and take part in a membrane binding region. Absence of Nt-acetylation is also associated with 
aggregation, suggesting a role in global protein folding. In some cases the Nt-acetyl group may act as a 
proteasomal degradation signal or blocking such a signal, regulating protein lifetime or turnover rate.  
(B) N-terminal acetylation of actin by NAA80/NatH affects cell morphology and migration rates as well as actin 
polymerization dynamics in vitro. 
(C) NatD/Naa40 is downregulated during calorie restriction-induced longevity in yeast and the following reduced 
Nt-acetylation of histone H4 is suggested to mediate the increased replicative age seen in starved yeast. Deletion 
of yeast naa40 mimic the effect of calorie restriction.  
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Nt-acetylation impacts protein aggregation and folding  
Nt-acetylation has been connected to protein aggregation with both positive and negative 
correlation, the latter depicted in Figure 4A-III. We know of two proteins whose pathology-causing 
aggregation processes is somehow slowed down by their Nt-acetylation. Aggregation of -synuclein 
(α-Syn) is a hallmark of Parkinson’s disease and other neuropathologies and in vivo this protein is 
fully Nt-acetylated. Although no Nt-acetylation-reducing disease variants have been characterized, in 
vitro experiments using the Nt-un-acetylated -Syn has shown that this version has a considerable 
higher rate of aggregation (Kang et al., 2012). This indicates the biological importance of this 
modification. At the protein level, addition of an acetyl group at the N-terminus of -Syn disrupts 
intermolecular hydrogen bonds that are important for α-Syn oligomerization, thereby decelerating the 
oligomerization process (Bu et al., 2017). Specifically, two H-bond donors at the N-terminus are 
absent in the presence of the Nt-acetyl group and this disrupts the intra molecular H-bond network (Bu 
et al., 2017). Thus, α-Syn is a very interesting case that demonstrates the importance of Nt-acetylation 
as the Nt-acetyl group is relevant for both aggregation propensity and membrane interaction as 
described above. 
Another protein that becomes prone to aggregation in the absence of Nt-acetylation, is 
huntingtin (Htt), although the possible direct effect of an Nt-acetyl group on Htt is less defined since 
Htt’s aggregation is prevented by the chaperone function of Htt-interacting protein K (HYPK) 
(Raychaudhuri et al., 2008) which is also a stable interactor in the NatA complex (Figure 2), that is 
necessary for its Nt-acetylation activity (Arnesen et al., 2010). Nevertheless, it appears that the NatA-
HYPK complex is essential in keeping Htt from aggregating, possibly through Nt-acetylation of Htt.  
An example in which Nt-acetylation facilitates rather than prevents aggregation is the NatA 
substrate Sup35. This protein forms amyloids in prion [PSI+] yeast cells and deletion of NatA in these 
yeast decreases the stability of Sup35 amyloid thereby relieving the phenotype of the [PSI+] cells 
(Holmes et al., 2014). The N-terminus of Sup35 is outside of the amyloid core, suggesting a 
cooperative or conformational effect related to protein structure, analogous to the intra protein H-bond 
effect for -Syn. Thus there are indications of a general effect of Nt-acetylation status on protein 
conformation or folding. Indeed, the same study (Holmes et al., 2014), proposed Nt-acetylation to 
have a global role in protein folding since Nt-acetylation deficiency in NatA-deleted yeast caused 
accumulation of misfolded proteins and increased levels of chaperones. However, indirect events may 
also come into play when studying global folding/aggregation effects resulting from depletion of 
NATs. For example, it was recently found that the yeast Hsp90 chaperone system is greatly impaired 
in cells depleted for NAA10, due to the unacetylated status of Hsp90 and several of its cochaperones 




Nt-acetylation impacts protein turnover through proteasomal degradation pathways  
For several decades, Nt-acetylation was considered to contribute to protein stability in vivo 
(Hershko et al., 1984). In 2010, this concept was challenged by the discovery of the Ac/N-degron 
(Hwang et al., 2010). Nt-acetylated protein termini starting with M, S, A, T, or V were identified as 
potential Ac/N-degrons which may be recognized by the E3 ubiquitin ligases Doa10 or Not4 and 
targeted for degradation (Hwang et al., 2010; Shemorry et al., 2013). Degradation of Nt-acetylated 
proteins appears to be particularly important in the context of protein quality control. Improper folding 
or abnormal stoichiometries of protein complex subunits may render certain protein N-termini 
exposed and thus available for the degradation machinery (Shemorry et al., 2013). At the same time, 
for several proteins like Hyx in Drosophila (Goetze et al., 2009) or the human THOC7 (Myklebust et 
al., 2015), Nt-acetylation certainly confers increased protein half-lives. 
An interesting example relevant for human physiology involves degradation of Rgs2 mediated 
through an Nt-acetylated as well as an unacetylated N-terminus. Rgs2 is a regulator of G-protein 
signaling and the wild type MQ-Rgs2 is fully Nt-acetylated by NatB and degraded via its Ac/N-
degron. However, an Rgs2 N-terminal variant associated with hypertension, ML-Rgs2, is only 
partially Nt-acetylated by NatC and thus may be degraded via both its Ac/N-degron or via its 
unacetylated N-terminus which is a classical Arg/N-degron (Varshavsky, 2019). In sum, the ML-Rgs2 
variant has a shorter half-life than the normal MQ-Rgs2 (degraded at least twice as rapidly) resulting 
in abnormal hypertension signaling in the patients expressing this variant (Aksnes et al., 2015a; Park 
et al., 2015). Thus both Nt-acetylated and unacetylated N-termini may act as degrons per se.  
A recent global investigation on yeast N-terminal degrons suggested that a quarter of all 
nascent protein N-termini may potentially encode degrons (Kats et al., 2018). However, this study 
suggested that the E3 ligase Doa10 primarily targets hydrophobic and not Nt-acetylated N-termini. 
Further, Nt-acetylation was found to inhibit degradation via Ubr1 and Arg/N-degrons. So while there 
is agreement on Nt-acetylated proteins not being targeted via the classical Arg/N-degron pathway as 
shown for Ubr1, the proteome-wide extent of the Ac/N-degron pathway needs further elaboration. 
While the most recent investigation is comprehensive and elegantly designed, it is still a reporter 
based system, so global investigations based on endogenous proteins in different cellular conditions 
are required to clarify this. Also, the relative contributions of the E3 ligases Not4 and Doa10 in the 
Ac/N-degron pathway are interesting to investigate further (Kats et al., 2018; Zattas et al., 2013).  
 
Nt-acetylation impacts cellular functions  
Although loss of Nt-acetylation is associated with many cellular abnormalities, the molecular 
basis of these have only been defined in a few cases. The highly selective NAT, NAA80, offers a 
unique possibility to study effects of Nt-acetylation on substrate function. NAA80’s substrate, actin, 
was indeed demonstrated to be impacted by the Nt-acetyl group in both its chemical and cellular 
functioning as shown in Figure 4B (Drazic et al., 2018). NAA80 knockout cells were here described to 
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have actin-related phenotypes, migrating more and with increased velocity compared to control cells 
holding Nt-acetylated actin. The cells with unacetylated actin also had an increased presence of 
protrusive structures characteristic of migrating cells and furthermore, actin purified from these cells 
had altered turnover of actin filaments. Actin has several binding partners that contribute to the 
regulation of its function and it is likely that actin’s Nt-acetyl group may contribute to some of its 
binding capacity. The hypermotility phenotype of the NAA80 knockout cells could suggest a role for 
NAA80 in keeping cellular migration at a healthy rate. In a cancer cell, the lack of proper NAA80 
function could conceivably induce cancer metastasis, an idea that seems plausible due to the 
localization of the NAA80 gene in a tumor-suppressor region (Wei et al., 1996). Actin is a key protein 
in a broad range of cellular functions and functional roles of actin Nt-acetylation are likely to be 
further defined as NAA80 deletion is further studied in additional model systems. 
Our knowledge on implications of Ntacetylation is growing as an increasing number of NAT 
knockout cells are characterized. A recent study using NAA20 and NAA25 knockout cells, found that 
Nt-acetylation by NatB is required for the shutoff activity of Influenza A virus and viral polymerase 
activity (Oishi et al., 2018). Influenza A virus suppresses, or shutoff, host gene expression through the 
viral endonuclease PA-X, that cleaves host mRNAs. An N-terminal endonuclease active site in PA-X, 
in addition to specific C-terminal basic amino acids, is important for its shutoff activity. Oishi and 
coworkers found that the shutoff activity of PA-X was suppressed in NatB-deficient cells and that Nt-
mutants of PA-X not matching the NatB specificity had reduced shutoff activities (Oishi et al., 2018). 
This work indicated that Nt-acetylation alone is not sufficient for PA-X shutoff activity, since mutants 
still matching NatB specificity (PA-X E2D and PA-X E2N) showed somewhat reduced shutoff 
activity and mutants fully Nt-acetylated by NatA (PA-X E2A), showed reduced shutoff activity. 
Yeast knockouts have had an important role in the early days of the Nt-acetylation field and 
now continue to contribute in expanding our understanding of how the Nt-acetyl group of certain 
proteins may be crucial for cellular function. A recent example is the deletion of Naa40 which causes 
prolonged lifespan under calorie restricted conditions, probably through decreased Nt-acetylation of 
the NatD substrate, histone H4 (Molina-Serrano et al., 2016). Here, histone H4 was found to be a 
regulator of yeast cellular lifespan in that it increases stress resistance and longevity as a response to 
calorie restriction. Interestingly, this mechanism seems to be regulated by the Nt-acetylation status of 
histone H4. Besides, NAA40 too seems to undergo regulation since calorie restriction caused its 
downregulation in addition to reduction in the levels of Nt-acetylated H4. The extended lifespan 
associated with calorie restriction was reduced upon overexpression of Naa40 associated with 
maintained levels of histone H4 Nt-acetylation. Similar to the previously shown effect of NatA 
depletion in plants (Linster et al., 2015), deletion of NAA40 in yeast mimics the effects of calorie 
restriction, here especially in the induction of stress-response genes. Hence this mutant is “primed” for 
scarce food supply, analogous to how the NatA depleted plants handle drought. This work also 
showed that an important regulator of calorie restriction-mediated longevity that prevents the 
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accumulation of intracellular nicotinamide during stress, nicotinamidase Pnc1, is required for naa40-
mediated longevity.  
Another recent paper also found a link between Nt-acetylation and NAD+/NADH metabolism 
as it described NatB as a NAD+ homeostasis factor in yeast (Croft et al., 2018). Here, NatB-deficient 
yeast flagged in a screen for mutants with increased release of the NAD+ intermediates NA and NAM. 
Also, the levels of NAD+ were significantly reduced in the NatB-deficient yeast and it was shown that 
decreased levels of the nicotinamide mononucleotide adenylyltransferases Nma1 and Nma2 likely 
caused these NAD+ defects. These two proteins were identified as NatB substrates, demonstrating that 
their Nt-acetylation status is essential for maintaining NAD+ levels. 
In C. elegans, Nt-acetylation is critical for the function of the NatB substrate SYP-1 (Gao et 
al., 2016). This protein is a component of the synaptonemal complex, a proteinaceous structure 
ubiquitously present during meiosis. NatB-mediated Nt-acetylation of SYP-1 is necessary for the 
assembly of this structure, elucidating a role for Nt-acetylation during meiosis. Further findings in this 
study suggested the importance of Nt-acetylation in regulating biological functions in the nucleus as 
there was an enrichment for global protein Nt-acetylation in the nuclear fraction (82%) compared with 
whole-worm lysates (74%). Interestingly, underlying this higher amount of Nt-acetylated proteins in 
the nucleus is an increased presence of N-termini with a high degree of Nt-acetylation (S-, NatA, 99%; 
MD-, NatB, 100%; and ME-, NatB 99%, (Aksnes et al., 2016)); accompanied with a decreased 
presence of N-termini with a low degree of Nt-acetylation (G-, NatA, 33%; P-, 0%; T-, NatA, 82%; 
and V-, NatA, 20%) (Gao et al., 2016). Taking these data together, Gao et al. suggest that Nt-
acetylated proteins might more readily form stable macromolecular structures in the nucleus, like the 
synaptonemal complex, perhaps through a facilitating function of Nt-acetylation in protein-protein 
interactions, as described above. 
 
 
NAA10 as a multifunctional protein?  
Defining the functional and biological roles is particularly challenging for one of the N-
terminal acetyltransferases, NAA10. Not only does NatA have the highest number of cellular 
substrates, but also, the catalytic subunit NAA10 seems to have extensive moonlighting functions. We 
here consider three aspects of NAA10 function. First, the canonical role as the catalytic subunit of the 
NatA complex. Second, the role of NAA10 as a posttranslational KAT. Third, NAA10 may have non-





NAA10 in the NatA complex 
Among the NATs, NAA10 is first in number of substrates, acetylating an estimated 40 % of 
the human proteome cotranslationally as part of the NatA complex (Arnesen et al., 2009). Binding to 
NAA15 ensures ribosomal anchoring and specificity for its large pool of cellular substrates (Liszczak 
et al., 2013). The result of these acetylation events are as diverse as the substrates, but generally the 
loss of NatA activity has been linked to diminished cell proliferation or increased cell death (Arnesen 
et al., 2006c; Fisher et al., 2005; Gromyko et al., 2010; Myklebust et al., 2015), lethality in 
Arabidopsis (Linster et al., 2015; Xu et al., 2015), as well as abnormal development in humans and in 
several model organisms (Ingram et al., 2000; Mullen et al., 1989; Ree et al., 2015; Rope et al., 2011; 
Sonnichsen et al., 2005; Wang et al., 2010) (Figure 5A). 
 
NAA10 as a KAT 
Several papers indicate that NAA10 has KAT activity, thus catalyzing the acetylation of -
amino groups on internal lysines (Figure 1). N-acetylation of -catenin is dependent on an interaction 
between NAA10 and -catenin, as well as normoxia (Lim et al., 2008; Lim et al., 2006). NAA10 auto-
N-acetylation enables NAA10 to N-acetylate -catenin, turn on the activating protein 1-pathway, 
and stimulate cell proliferation (Seo et al., 2010). NAA10 has been implicated in the degradation of 
HIF-1, by N-acetylating it and furthering its targeting by the proteasome by increasing the affinity 
of HIF-1 to the E3 ligase Von Hippel Lindau protein (Jeong et al., 2002). During hypoxia, HIF-1 is 
not hydroxylated and is free to translocate to the nucleus and activate the hypoxic response (Figure 
5B, left). This claim has been disputed, as replication efforts failed to find neither an increase in 
hypoxia response genes, nor that the short half-life of HIF-1 under normoxia is increased by NAA10 
depletion (Bilton et al., 2005; Fisher et al., 2005). Furthermore, NAA10 was not able to acetylate HIF-
1 in vitro (Arnesen et al., 2005b). Nevertheless, a recent study shed light on how this acetylation may 
take place, showing that NAA10 is hydroxylated on C-2 of the indole ring of Trp38 by factor 
inhibiting HIF-1 (FIH) during normoxia and suggesting that this oxygen-dependent hydroxylation 
results in a conformational change in NAA10. Hydroxylation was suggested, by molecular dynamics 
simulations, to widen the substrate gate of NAA10, allowing it to accommodate the target lysine of 
HIF-1 (Kang et al., 2018), thus indicating a regulation of NAT versus KAT activity that is responsive 
to oxygen conditions (Figure 5B, left).  
A number of additional KAT targets of NAA10 have been proposed. N-acetylation of the cell 
cycle regulator Cdc25A by NAA10 increases its stability, and this happens as a response to genotoxic 
stress. This acetylation, which can be reversed by HDAC11, is suggested to allow time for DNA repair 
after DNA damage (Lozada et al., 2016). NAA10 is also able to promote autophagosome nucleation 
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through N-acetylation of phosphoglycerate kinase 1 (PGK1) (Figure 5C). Also in this case, oxygen 
conditions affect post-translational modification of NAA10. During normoxia, NAA10 is 
phosphorylated by mammalian target of rapamycin (mTOR), blocking its interaction with PGK1. 
Hypoxia or glutamine deprivation inhibits mTOR so that NAA10 is allowed to N-acetylate PGK1, 
which in turn may phosphorylate Beclin1 and start the process of autophagosome nucleation. NAA10 
thus regulates nutrient availability and macromolecule recirculation through induction of autophagy 
under hypoxic or stress conditions. Heat shock protein 70 (Hsp70) works to promote protein refolding 
during the immediate time after chemical stress. NAA10 is also involved in stress response through 
N-acetylation of Hsp70, increasing the affinity of Hsp70 for a co-chaperone, thus promoting its 
refolding activity (Seo et al., 2016). Further, NAA10 interacts with and N-acetylates androgen 
receptor (AR), a mechanistic explanation for the fact that NAA10 is upregulated in prostate cancer. By 
acetylating AR, NAA10 promotes the expression of AR target genes (Wang et al., 2012). Finally, 
NAA10 is reported to N-acetylate the deoxynucleotide triphosphohydrolase SAM domain and HD 
domain containing protein 1 (SAMHD1). SAMHD1 acetylation leads to increased proliferation 
through promoting G1 to S-phase transition (Lee et al., 2017b). 
From a structural point of view the KAT activity of NAA10  is controversial, as 
crystallographic structures indicate that there is not enough space in the groove between the 1-2 
and 6-7 loops to accommodate a lysine substrate, only an N-terminal substrate (Figure 6A) 
(Gottlieb and Marmorstein, 2018; Liszczak et al., 2013). Several of the KAT substrates have so far 
failed to be replicated biochemically, and some results may stem from non-enzymatic acetylation 
(Magin et al., 2016). Indeed, non-enzymatic lysine acetylation occurs in a non-random manner and 
appears to be biased towards lysine sites with flanking basic residues, or where basic residues are 
found nearby in the 3D folding of a protein (Baeza et al., 2015). This also holds true for mitochondrial 
acetylation sites which are regulated by Sirt3 (Hebert et al., 2013) and are considered to be products of 
non-enzymatic acetylation (reviewed in Drazic et al., 2016). Two of the lysine sites discussed by 
Magin et al., Runx2 and MSRA, are found in basic patches of the protein 3D structure (Magin et al., 
2016). This may explain why Magin found them to be readily non-enzymatically acetylated, and lends 
credence to the idea that they are not true NAA10 substrates. The molecular dynamics simulation of 
the consequence of a novel PTM on NAA10, Trp38 hydroxylation, may hold a clue as to how these 
opposing views may be reconciled (Kang et al., 2018). More research is needed to clarify under what 
conditions NAA10 can shift from a NAT to a KAT and to what degree such a change in structure 





Non-catalytic roles of NAA10 
NAA10 interacts with several proteins in a functionally meaningful manner. In addition to the 
reported substrate interactions described above (HIF-1, Hsp70, SAMHD1, PGK1, Cdcd25A and 
AR), NAA10 can also affect binding partners in acetyltransferase-independent manners. In the case of 
signal transducer and activator of transcription 5a (STAT5a), NAA10 interaction decreases the 
expression of STAT5a target genes, in particular inhibitor of differentiation 1 (ID1). ID1 is considered 
to promote metastasis, and STAT5a is an essential driver of ID1 expression. The authors observed that 
NAA10 expression correlates inversely with metastasis, which may be explained in part by this 
inhibitory, acetyltransferase independent effect on STAT5a (Zeng et al., 2014).  
Another described interactor of NAA10 is PIX. At the leading edge of a migrating cell, 
GTPases, guanine nucleotide exchange factors (GEFs), and extracellular matrix anchors cooperate at 
focal adhesions to drive the cell edge forward. One such complex consists of, among other proteins, 
the G protein-coupled receptor kinase-interacting protein (GIT) (a GTPase-activating protein), and 
p21-activated kinase interacting exchange factor (PIX, a GEF). NAA10 interacts with PIX and 
disrupts its binding to GIT, thus reducing Cdc42 and Rac1 activity at focal adhesions and decreasing 
the rate of cell migration (Hua et al., 2011). Interestingly, in both these cases, NAA10 appears to have 
an anti-metastatic function, inhibiting either the downstream effects of ID1 or cell migration capability 
through disruption of a migratory complex.  
A completely different role of NAA10 was also presented, namely a direct binding to 
particular non-methylated DNA motifs and recruitment of DNA methyltransferase 1 (DNMT1) 
(Figure 5B, right). This maintains genomic imprinting, silencing genes that are not to be expressed, 
but may also silence tumor suppressor genes and contribute to cancer development (Lee et al., 2017a; 
Lee et al., 2010). Naa10 KO mice have several developmental defects, and 35 % male and 27 % 
female pups die prenatally, mainly as a result of placental deficiency. Surviving pups have retarded 
growth and hydrocephalus with dilated ventricles. Surviving heterozygous females are fertile, but have 
low body weight and decreased litter size. Heterozygous pups born of homozygous Naa10-/- mothers 
had a low perinatal survival rate, which was attributed to a maternal effect, given that heterozygous 
pups from heterozygous females and wildtype males survived for longer after birth. NAA10’s 
interaction with DNMT1 is acetyltransferase-independent (Lee et al., 2010), and when disrupted, leads 
to widespread dysregulation of genomic imprinting (Lee et al., 2017a). The paralog NAA11 has some 
functional redundancy with NAA10 (Arnesen et al., 2006b) and this might explain why the Naa10 KO 
mice are viable and fertile. The degree to which NAA11 or other paralogs or NATs can substitute for 





Figure 5. The diverse catalytic and non-catalytic roles of NAA10.  
(A) The classical role of NAA10 as the catalytic subunit of the NatA complex. NatA is found on the ribosome and 
acetylates approximately 40 % of all nascent N-termini cotranslationally, contributing to diverse cellular functions, 
such as proliferation, normal organismal development, and as an oncoprotein and potentially a tumor suppressor, 
depending on the context and the function of the N-terminally acetylated protein.  
(B) Examples of non-classical roles of NAA10 as a KAT (left) and a non-catalytic regulator (right). Left: NAA10 is 
hydroxylated during normoxia by factor inhibiting HIF-1α (FIH), which also hydroxylates HIF-1α. Upon 
hydroxylation, a loop in NAA10 shifts, enabling NAA10 to accommodate lysine substrates and N-acetylate HIF-
1α. This contributes to the instability and subsequent proteasomal degradation of HIF1α. During hypoxia, neither 
NAA10 nor HIF-1α are hydroxylated, and HIF-1α is free to translocate to the nucleus and promote transcription of 
hypoxia response genes. Right: an acetyltransferase-independent function of NAA10. DNA methyltransferase 1 
(DNMT1) is recruited to CpG islands by NAA10, which binds to nonmethylated DNA regions. DNMT1 binding to 
CpG islands furthers genomic imprinting and tumor suppressor silencing. Imprinting is required for normal murine 
development, but may also contribute to cancer progression. 
(C) Example of non-classical role of NAA10 as a KAT. NAA10 phosphorylation by mammalian target of rapamycin 
(mTOR) is inhibited in states of hypoxia or glutamine deprivation. Loss of phosphorylation leads to NAA10 
interaction with PGK1 and N-acetylation of a PGK1 lysine. Acetylated PGK1 is able to phosphorylate Beclin1 and 
Beclin1-mediated autophagosome nucleation and autophagy may occur. 
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Emerging roles of NATs in human pathology 
NatA variants cause developmental syndromes  
The list of identified NAA10 mutations in patients has grown substantially since 2011, 
implicating Nt-acetylation in congenital syndromes and non-syndromic developmental delay (Figure 
6, Table 1). There is considerable heterogeneity in the presentation and severity of cases of NAA10 
deficiency, but broadly, mutations in conserved regions of NAA10 are associated with intellectual 
disability, developmental delay, growth failure, and specific organ development phenotypes, including 
skeletal, cardiac and ophthalmological abnormalities (Table 1). The genotype-phenotype relationship 
is complex, and does not depend directly on the loss of catalytic activity. Some variants, like 
Ser37Pro, which is the cause of Ogden syndrome, leads to a modest reduction in in vitro activity but 
has a very severe clinical presentation (Rope et al., 2011), while the Ile72Thr variant is at least as 
reduced for the monomeric activity, but nevertheless leads to a comparatively mild phenotype (Stove 
et al., 2018). 
NAA10 is located on the X chromosome, and hemizygous males would be expected to have 
graver symptoms of NAA10 deficiency than heterozygous females. However, in the case of very 
damaging mutations, female carriers may still exhibit serious symptoms, while male hemizygotes 
would not be viable and perish at an early age. One of the AcCoA binding mutations (Arg83Cys), 
which results in a very limited catalytic capacity, could be such a case. A mother who is germline 
mosaic for the variant gave birth to a boy who died at one week of age (Saunier et al., 2016).  
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Table 1: Patient mutations in NAA10 and their consequences. ID: intellectual disability; DD: 
developmental delay.  
Mutation Patients Symptoms Functional effect References 
Ser37Pro  
8 male , 5 female 
carriers (mothers of 
affected boys) 
Global DD; craniofacial 
abnormalities; aged 
appearance; cardiac 
arrhythmia; death in 
infancy 
Decreased catalytic 
activity; impaired NAA15 
and NAA50 interaction; 
decreased binding to 
ICRs; patient fibroblasts 
have decreased Nt-
acetylation; abnormal cell 
migration and 
proliferation 
(Lee et al., 2017a; 
Myklebust et al., 
2015; Rope et al., 
2011) 
Tyr43Ser 
2 male (brothers), 1 
heterozygous female 
with some symptoms 
(their mother) 
ID; facial dysmorphism; 
scoliosis; long QT 
Decreased catalytic 
activity; unstable  
(Casey et al., 
2015) 
Ile72Thr 
3 male (2 brothers, 1 
unrelated) 
DD; ID; cardiac 
abnormalities 
Decreased monomeric 
catalytic activity; unstable 
(Stove et al., 
2018) 
Arg83Cys 
8 females (1 girl and 
2 deceased boys are 
siblings; the rest de 
novo), 2 males 





(Saunier et al., 
2016) 
Val107Phe 1 female 
ID; abnormal muscle 





binding to ICRs (Popp et al., 2015) 
Val111Gly 
1 female 
ID; delayed motor and 
language development 
Decreased monomeric 
catalytic activity; unstable 
(McTiernan et al., 
2018) 
Arg116Trp 
1 male, 1 female 
(unrelated) 
ID; abnormal muscle 
tone; growth failure; 
skeletal abnormalities 
Small reduction in 
catalytic activity; 
decreased binding to 
ICRs 
(Lee et al., 2017a; 
Popp et al., 2015; 
Rauch et al., 




ID; growth failure; 
abnormal muscle tone 
Decreased stability; 
enzymatic activity not 
assessed 
(Saunier et al., 
2016; Thevenon 
et al., 2016) 
Phe128Leu 
2 females (unrelated) 






(Saunier et al., 
2016) 
c.471+2T  A 
8 male (3 brothers, 4 
others in same family) 






enzymatic activity not 
assessed; patient 
fibroblasts have cell 
proliferation defects 




Functional in vitro experimental work on NAA10 variants suggests that mutations may 
manifest themselves in three different ways at the protein level.  
First, a mutation may cause the catalytic activity of NAA10 to diminish. This happens through 
abrogated interaction with a substrate – either AcCoA or the peptide substrate – or through missense 
mutation at a site directly involved in catalysis. Such mutations result in enzymes that are readily 
purified and stable, but have decreased catalytic capacity. Molecular dynamics simulations indicate 
that the Ser37Pro mutation impairs the flexibility of the substrate-binding region (Myklebust et al., 
2015). The Arg83Cys mutation has a more direct impact as it affects the interaction of NAA10 with 
AcCoA (Saunier et al., 2016), and shows a heavily reduced catalytic activity. It would be presumed 
that all catalytic activities, NAT as well as KAT, would be impaired for such mutants. 
Second, a structural or destabilizing mutant may cause NAA10 to be misfolded, and the 
misfolded protein to be rapidly degraded. Such mutations make the enzyme difficult to purify. 
Necessarily, they also cause a loss of in vitro and in vivo catalytic efficiency, and will have shorter 
half-lives. As Phe128 is located in a hydrophobic pocket at the core of NAA10, the Phe128Leu 
mutation was predicted to destabilize the fold and lead to a loss of enzymatic activity and stability, as 
was observed (Saunier et al., 2016). Some of these destabilizing variants like NAA10 V111G and 
I72T display interesting in vitro data suggesting that when bound to NAA15, the NatA complex NAT-
activity is intact, while the monomeric catalytic activity is strongly impaired (McTiernan et al., 2018; 
Stove et al., 2018). In vivo evidence is missing, but this would support non-NatA impairment as 
causative for disease.    
Third, a mutation located to the interface between NAA10 and another protein or 
macromolecule may lead to functional impairment. Mutations that affect association with NAA15 may 
interfere with NatA complex formation. In the case of such mutations, it is expected that 
cotranslational NatA activity is reduced, while the NAT and KAT activity of NAA10 towards 
posttranslational substrates may be unaffected or only mildly impaired. Although Ser37 does not 
directly interact with NAA15, mutation of Ser37 to a Pro shortens and shifts a helix which is involved 
in NAA15 binding (Myklebust et al., 2015). Recently, a novel role for NAA10 as a DNA-binding 
protein was described. Three patient mutations apparently disrupt NAA10 binding to imprinting 
control regions (ICRs) (Lee et al., 2017a) (Table 1). This suggests that some of the symptoms seen in 
these patients could be due to a disruption of NAA10 and its role in genomic imprinting maintenance.  
Some mutations in the NAA15 gene, encoding the ribosome-binding subunit of NatA, have 
also been described, with a clinical picture overlapping with NAA10 mutations. NAA15 has been 
identified in screens for novel intellectual disability-associated genes (Zhao et al., 2018) and for 
variants associated with autism or developmental disability (Stessman et al., 2017). Comparing 38 
cases of 25 different NAA15 variants, including splice-site, frameshift and missense mutations, a 
clinical picture with considerable heterogeneity, yet with some central common features, could be 
seen, Patients had neurodevelopmental disabilities including intellectual disability, autism spectrum 
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disorder, impaired motor function, as well as delayed development. Some had cardiac anomalies and 
facial dysmorphia (Cheng et al., 2018). Seen in connection with the common feature of intellectual 
disability or neuromotor impairment in all cases of NAA10 and NAA15 mutation, this suggests that 
NatA has a crucial function in brain development, and further that at least some of these phenotypes 
are caused by an impaired NatA function (in contrast to NatA independent functions of NAA10 and 
NAA15). 
 
Figure 6. Structure of NAA10 and location of pathological mutation sites. A structural model of NAA10 with 
SASE peptide substrate and CoA was made in PyMol by aligning the structure of human NAA10 in complex with 
NAA15 (not shown) (PDB ID: 6C9M; (Gottlieb and Marmorstein, 2018)) to the structure of Schizosaccharomyces 
pombe NAA10 solved in complex with NAA15 (not shown), CoA and substrate peptide (4KVM; (Liszczak et al., 
2013)). CoA is shown as a licorice model colored according to element, SASE substrate peptide is represented in 
green, CoA-binding residues in yellow and NAA15-binding residues in blue. Mutation sites are indicated with 
arrows. 
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NATs in cancer 
Many of the NATs have an impact on cancer cell proliferation or survival and likely have a 
role as oncoproteins (Drazic et al., 2016; Kalvik and Arnesen, 2013). In particular NAA10 was found 
to play a key role in many cancer types. Several cancer tissues and cells display elevated levels of 
NAA10 as compared to non-cancer tissues including breast cancer, urinary bladder cancer, oral 
squamous cell carcinoma, hepatocellular carcinoma, colorectal cancer, lung cancer and prostate cancer 
(Lee et al., 2010; Midorikawa et al., 2002; Ren et al., 2008; Wang et al., 2012; Yu et al., 2009a; Yu et 
al., 2009b; Zeng et al., 2016). In several cases, increased NAA10 expression is correlated with 
increased tumor aggressiveness and low survival. However, also the opposite or more complex 
correlations may be found. For instance, in oral squamous cell carcinomas NAA10 is overexpressed in 
tumor tissue, but at the same time increased NAA10 is correlated with negative lymph node status and 
lower recurrence rates in patients (Zeng et al., 2016). Since NAA10 potentially has many modes of 
action as discussed earlier, the interpretation of the exact substrates and signaling pathways through 
which it impacts cancer cells is complicated. This ranges from its major role in the NatA complex as a 
NAT (Arnesen et al., 2006c; Gromyko et al., 2010) to various KAT activities towards specific 
substrates (Lee et al., 2017b; Lim et al., 2006; Qian et al., 2017; Seo et al., 2016; Shin et al., 2009; 
Shin et al., 2014; Vo et al., 2017; Wang et al., 2012; Yoon et al., 2014) and non-catalytic roles (Hua et 
al., 2011; Lee et al., 2017a). The cancer relevance of the KAT and non-catalytic roles of NAA10 are 
increasingly underpinned. Recent insights include two novel KAT targets of NAA10, SAMHD1 and 
Aurora kinase A, in which N-acetylation of both these proteins promote cancer cell proliferation. For 
the dNTPase SAMHD1, NAA10 mediated acetylation of Lys405 enhanced its catalytic activity (Lee 
et al., 2017b), while for Aurora kinase A acetylation of Lys75 and Lys125 increased the kinase 
activity and thus promoted cell cycle progression.   
Autophagy is a process where proteins are broken down into constituent components for 
recycling during times of starvation or stress. However, cancer cells can also upregulate autophagy 
when subjected to nutrient stress or oxygen deprivation, allowing them to survive in tumor interiors 
with poor vascularization. NAA10 can induce autophagy by different mechanisms. Qian and 
colleagues subjected glioblastoma cells to glutamine deprivation or hypoxia, which inhibits mTOR 
signaling. They found that NAA10 interacts with phosphoglycerate kinase 1 (PGK1) and acetylates it 
on an internal lysine. This signals PGK1 to phosphorylate Beclin1 and induce the formation of an 
autophagosome, and increases the tumorigenicity of glioblastoma cells (Qian et al., 2017) (Figure 5C). 
In another mechanism, NAA10 indirectly acts as an inhibitor of mTOR. IκB kinase β (IKKβ), a kinase 
which acts downstream of tumor necrosis factor α, phosphorylates and targets for degradation two 
tumor suppressors, tuberous sclerosis complex 1 and forkhead box O3. In breast cancer cells, IKKβ 
phosphorylates NAA10 and targets it for degradation (Kuo et al., 2009). NAA10 acts on mTOR to 
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inhibit its activity and promote autophagy. However, it also acetylates Hsp70, promoting autophagy 
through a distinct mechanism (Zhang et al., 2018). 
A suggested role of NAA10 as a metastasis suppressor is based on several independent studies 
(Hua et al., 2011; Shin et al., 2009; Zeng et al., 2016). Mechanistically, this motility inhibition has two 
alternative explanations: a) NAA10 non-catalytically binds to p21-activated kinase (PAK)-interacting 
exchange factor (PIX) proteins and prevents formation of the GIT-PIX-Paxillin complex and 
subsequent activation of Rac1/Cdc42 (Hua et al., 2011), and b) NAA10 binds and acetylates Lys608 
of MLCK thereby inhibiting the MLCK catalyzed phosphorylation of MLC (Shin et al., 2009).  
Understanding the multifaceted roles of NAA10 in tumor progression and metastasis will 
remain a major challenge for future studies. With the numerous NAT, KAT, and non-catalytic targets 
of NAA10, and the huge variability in activated signaling pathways in different cancer cells, this is not 
straightforward. 
NatB, NatC and NatD were all recently presented as vital for cancer cell survival and 
proliferation. NatB subunits are overexpressed in hepatocellular carcinoma and NatB mediated Nt-
acetylation of tropomyosin and CDK2 contributes to cancer cell proliferation (Neri et al., 2017). NatC 
catalytic subunit NAA30 increases cancer cell viability when overexpressed (Varland et al., 2018b), 
while depletion of NAA30 disrupts mitochondrial function (Van Damme et al., 2016) and in 
glioblastoma initiating cells tumorigenic features are reduced (Mughal et al., 2015). NatD is essential 
for colon cancer cell survival (Pavlou and Kirmizis, 2016). In primary human lung cancer NatD was 
found to be upregulated and correlated with decreased survival rates (Ju et al., 2017). Cancer 
migration was mediated via Slug and repression of the epithelial to mesenchymal transition. Recently, 
also NatH/NAA80 mediated actin Nt-acetylation was revealed as a potential inhibitor of cancer cell 
motility (Drazic et al., 2018), as described above.  
 
Nt acetylation of -Synuclein and Parkinson’s disease  
Parkinson’s disease (PD) is a neurodegenerative disease in which aggregation of the abundant 
presynaptic protein, α-Synuclein (α-Syn) is the major cause (Goedert, 2001). As described above, Nt-
acetylation has a protective effect against α-Syn oligomerization. Formation of oligomers is the initial 
part of the PD pathogenesis as these may function as aggregation seeds. For mutated versions of α-Syn 
that are associated with early-onset Parkinson’s disease (A30P, E46K and A53T), the anti-aggregation 
effect of Nt-acetylation becomes impaired, suggesting a cooperative link between the regions of these 
mutations and the N-terminus (Ruzafa et al., 2017). PD specifically affects dopaminergic neurons and 
a neurotoxic effect on α-Syn caused by DOPAL (3,4-dihydroxyphenylacetaldehyde), a biproduct in 
the synthesis of dopamine, has been investigated by Lima and coworkers, amongst others (Lima et al., 
2018). Very recently they found that wildtype Nt-acetylated α-Syn is less prone to form oligomers in 
the presence of DOPAL than the non-Nt-acetylated α-Syn, whereas the opposite was found for 
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inherited mutations of α-Syn (A53T, E46K and H50Q) (Lima et al., 2018).  
These recent studies on -Syn underline the importance of using correctly modified (Nt-
acetylated) α-synuclein in biochemical studies. Of particular interest in that regard, is a recently 
optimized recombinant expression system for rapid production of Nt-acetylated proteins that can be 




Concluding remarks and future perspectives 
A majority of eukaryotic proteins are Nt-acetylated and it is likely that we have now identified 
most of the components of the NAT machinery acting in the cytosol. At the same time, it is possible 
that there are yet to be discovered specific proteins, like actin, that require Nt-acetylation by a 
dedicated NAT. With NatF and NatG, the first organelle associated NATs have emerged (Aksnes et 
al., 2015c; Dinh et al., 2015), but in contrast to cytosolic NATs, it is quite likely that the collection of 
organellar NATs will expand in the future when the cellular compartments are further investigated.  
The regulation of Nt-acetylation remains enigmatic, but may be on its way into the limelight. 
Transcriptional downregulation of NatA and an apparent downstream reduction of Nt-acetylation by 
drought-stress in plants represents a rare example (Linster et al., 2015), but was recently paralleled by 
NatD’s role in calorie restriction-induced longevity in yeast (Molina-Serrano et al., 2016). It would be 
interesting to explore this regulation in more detail and elucidate the role of Nt-acetylation in response 
to abiotic and biotic stresses as well as longevity studies in additional model organisms. Regulation 
could also occur through enzyme activation or inactivation via PTMs or similar, but such cases are yet 
limited to the examples regulating the KAT activity of NAA10. The cellular concentration of acetyl-
CoA could impact Nt-acetylation rates, but this does not appear to be a general regulation mechanism 
(Varland et al., 2018a; Yi et al., 2011). Finally, the Nt-acetylation reaction could be reversible by the 
action of N-terminal deacetylases (NDACs) similar to KDACs acting on acetylated lysine residues. 
NDAC activity could fulfill a specific regulatory function by acting on particular targets. It could for 
example regulate protein half-lives or protein-protein or -lipid interactions as a response to cellular 
signaling. However, an NDAC enzyme is yet to be discovered. 
Crosstalk and potential competition between Nt-acetylation and other N-terminal 
modifications could constitute a way for Nt-acetylation to indirectly pose regulation on a wide range 
of cellular functions. Nt-acetylation could for example counteract the effects of modifications such as 
Nt-myristoylation, Nt-methylation, or Nt-ubiquitination. Such crosstalk is thus far only at the 
beginning of its characterization and it would be important to explore the extent of its regulatory 
complexity at the molecular, cellular and organismal level. 
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Nt-acetylation may impact proteins in terms of complex formation, subcellular targeting, 
folding, aggregation, stabilization and degradation. However, for most proteins the impact has not 
been uncovered, and for some it is possible that Nt-acetylation does not have any major functional 
effect that is measurable on the single protein level. However, loss of Nt-acetylation is associated with 
many cellular phenotypes and given the number of substrates for a typical NAT, the underlying 
molecular mechanisms could be combinatorial. The recent global investigations are beginning to shed 
light on this perspective. Based on the important role of Nt-acetylation in development and in 
surviving conditions of stress and scarce food it could be hypothesized that subtle changes in the Nt-
acetylation status of multiple proteins could in a way “set the stage” for various cellular and metabolic 
conditions. Such global combinatorial effects are less accessible to research, but could perhaps be 
addressed with large-scale proteomics and systems biology. For the high-selectivity NAT, 
NatH/NAA80, the substrate actin, which is the most abundant cellular protein, was recently shown to 
be affected by its Nt-acetyl group at both biochemical and cellular levels (Drazic et al., 2018). The 
animal kingdom processing and Nt-acetylation by NatH/NAA80 turns out to be a key factor in actin 
polymerization dynamics and cell motility. Future studies will unravel further molecular effects on 
actin function and not least why animal actins require this unique N-terminal processing. 
A new direction in NAT research is undoubtedly the emerging moonlighting functions, in 
particular for NAA10. While the evolutionarily conserved role of NATs is catalyzing Nt-acetylation 
(Arnesen et al., 2009), many studies point to mammalian NAA10 as a KAT (Lee et al., 2017b; Lim et 
al., 2006; Qian et al., 2017; Seo et al., 2016; Shin et al., 2009; Shin et al., 2014; Wang et al., 2012; 
Yoon et al., 2014) or as a non-catalytic regulator (Hua et al., 2011; Lee et al., 2017a) of signaling 
pathways coupled to autophagy, cell stress, hypoxia, apoptosis, cell division and cell motility. A 
recently proposed mechanistic explanation for this NAA10 duality is the hydroxylation state of 
NAA10, where a non-hydroxylated pool of NAA10 has NAT activity while the hydroxylated NAA10 
has KAT activity (Kang et al., 2018). This oxygen dependent hydroxylation would ensure NAA10 
mediated KAT acetylation and degradation of HIF-1α, but the generality of this observation remains to 
be investigated. 
In conclusion, the field is now entering an exciting phase where mechanisms of regulation and 
biological impact are likely to be key aspects. 
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